Dark

Check out our API

ENDP
Endo International plc
stock NASDAQ

Inactive

Aug 25, 2022

0.2926USD-5.000%(-0.0154)44,437,233

Pre-market

0.00USD-100.000%(-0.31)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 25, 2022

05:01PM EST Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results PR Newswire

Jan 18, 2022

07:17AM EST Endo International plc (ENDP) announced Tuesday that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc. and Endo Health Solutions Inc. have entered into a statewide settlement agreement intended to resolve all government-related opioid claims in Florida. RTTNews

07:03AM EST Endo Reaches Agreement Intended To Settle Florida Governmental Opioid Cases And Claims For $65M Benzinga

07:02AM EST Endo Reaches Agreement Intended To Settle Florida Governmental Opioid Cases And Claims RTTNews

07:02AM EST Endo Enters Into Statewide Settlement Agreement Intended To Resolve All Government-related Opioid Claims In Florida RTTNews

07:01AM EST Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and PR Newswire

Jan 17, 2022

07:38AM EST Paladin Labs Inc., a unit of Endo International plc (ENDP), said Xydalba (dalbavancin for injection), a 30-minute intravenous therapy for acute bacterial skin and skin structure infections that can be administered as a single- or two-dose regimen, is now available to patients nationwide in Canada. RTTNews

07:32AM EST Paladin Labs Announces The Launch Of Xydalba In Canada RTTNews

Jan 13, 2022

11:46AM EST Endo Announces Publication Of New AVEED Data In Peer-Reviewed Journal Of Clinical Pharmacology; Data Evaluates Dosing Flexibility In Men With Hypogonadism Benzinga

07:54AM EST Endo Reports Findings From PK Simulation Modeling Study In RTTNews

07:32AM EST Endo Announces Publication Of New AVEED Data; Data Evaluates Dosing Flexibility In Men With Hypogonadism RTTNews

07:31AM EST Peer-Reviewed Journal of Clinical Pharmacology; Data Evaluates Dosing Flexibility in Men With Hypogonadism PR Newswire

Jan 11, 2022

07:01AM EST Endo Appoints James Tursi As EVP, Global Research & Development RTTNews

07:01AM EST Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & PR Newswire

Jan 10, 2022

07:32AM EST Endo Launches New Dupuytren's Contracture Campaign RTTNews

07:31AM EST Endo Launches New Dupuytren's Contracture Campaign Featuring Real Patients: PR Newswire

Jan 4, 2022

06:26PM EST Endo Launches First Generic Version of CUVPOSA(r) (glycopyrrolate) Oral Solution PR Newswire

05:01PM EST Endo to Participate at J.P. Morgan 40th Annual Healthcare Conference PR Newswire

Dec 24, 2021

06:15AM EST Endo International plc (ENDP) agreed to pay $63 million to settle all government-related opioid claims in Texas. RTTNews

Dec 23, 2021

02:20PM EST Endo Int'l. Reports Deal Intended To Settle Texas Governmental Opioid Cases, Claims; Payment Would Be $63M Benzinga

02:20PM EST Endo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and PR Newswire

06:28AM EST Endo International plc (ENDP) announced Thursday that its unit Endo Ventures Limited has entered into definitive agreements with SK Biopharmaceuticals for the development, registration, supply, commercialization and distribution of cenobamate on an exclusive basis in Canada. RTTNews

06:02AM EST Endo Ventures Enters Deal With SK Biopharmaceuticals For Development Of Cenobamate In Canada RTTNews

06:01AM EST Endo Int'l. Reports Deal With Paladin Labs To Commercialize SK Biopharma's XCOPRI In Canada, No Terms Disclosed Benzinga

06:00AM EST Endo Announces Agreement for Paladin Labs to Commercialize SK PR Newswire

Dec 16, 2021

07:40AM EST Barclays Maintains Equal-Weight on Endo International, Lowers Price Target to $5 Benzinga

Dec 15, 2021

10:24AM EST Endo Announces Favorable Final Ruling In California State Court Opioid Trial Benzinga

10:01AM EST Price Over Earnings Overview: Endo International Benzinga

09:48AM EST Endo Issues 'Public Statement Against Use of Medicines for Capital Punishment' Benzinga

08:03AM EST The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO Benzinga

Dec 12, 2021

04:56PM EST The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More Benzinga

Dec 2, 2021

12:02PM EST Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates Benzinga

Nov 22, 2021

10:57AM EST Endo's Qwo Data Presented At American Society For Dermatologic Surgery's Annual Meeting Benzinga

10:54AM EST Endo's Qwo(r) (collagenase clostridium histolyticum-aaes) Data Presented at the PR Newswire

09:02AM EST Settlement Administrator Angeion Group Announces Proposed Class Action PR Newswire

Nov 18, 2021

08:07AM EST Pharmaceutical company Endo International plc (ENDP) announced Thursday that its Par Sterile Products business has begun shipping calcitonin salmon injection, USP, multi-dose vials (2 mL) following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application. RTTNews

07:41AM EST Endo Int'l. Reports Begun Shipping Generic MIACALCIN Injection Benzinga

07:32AM EST Endo Begins Shipment Of Calcitonin Salmon Injection, USP, Multi-dose Vials RTTNews

07:31AM EST Endo Begins Shipment of Generic MIACALCIN(r) (calcitonin salmon) Injection PR Newswire

Nov 17, 2021

08:09AM EST Endo International Plc (ENDP) or Endo, a pharmaceutical company, on Wednesday said its subsidiary, Par Sterile Products, LLC, has joined hands with the U.S. government to establish a new plant at an estimated cost of $120 million to support the production of critical medicines. RTTNews

07:41AM EST Endo Announces Fill-Finish Manufacturing Agreement With US Government To 'Support Production of Critical Medicines' Benzinga

07:32AM EST Endo Announces Agreement With U.S. Government To Support Production Of Critical Medicines RTTNews

07:31AM EST Endo Announces Fill-Finish Manufacturing Agreement with U.S. Government to PR Newswire

Nov 8, 2021

08:02AM EST Specialty pharmaceutical company Endo International plc (ENDP) said its Par Sterile Products business will supply VASOSTRICT, vasopressin injection, USP, vial presentations to healthcare providers through Premier's Premier ProRx program. RTTNews

07:32AM EST Endo Agrees With Premier To Supply VASOSTRICT, Vasopressin Injection, USP, Vial, Essential For COVID-19 Care RTTNews

07:31AM EST Endo Announces Agreement with Premier to Supply VASOSTRICT(r) (vasopressin PR Newswire

07:31AM EST Endo Announces Agreement With Premier To Supply VASOSTRICT Vials, Essential For COVID-19 Care Benzinga

Nov 5, 2021

09:32AM EDT Endo Raises FY21 Total Sales From $2.73B-$2.79B To $2.9B-$2.94B vs $2.79B Estimate, Adj. EPS $2.15-$2.30 To $2.80-$2.85 vs $2.33 Est. Benzinga

09:32AM EDT Endo International Q3 Adj. EPS $0.80 Beats $0.48 Estimate, Sales $772.03M Beat $669.71M Estimate; Raises Guidance Benzinga

Nov 4, 2021

10:54PM EDT Endo International plc (ENDP) raised its fiscal year 2021 adjusted net income per share from continuing operations outlook to a range of $2.80 - $2.85 from the prior estimation of $2.15 - $2.30. Analysts polled by Thomson Reuters expect the company to report earnings of $2.33 per share for fiscal year 2021. Analysts' estimates typically exclude special items. RTTNews

04:27PM EDT Endo Q3 Loss/share $0.33, Same As Last Year RTTNews

04:16PM EDT Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial PR Newswire

08:19AM EDT The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO Benzinga

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Nov 2, 2021

10:49AM EDT Endo Int'l. Reports California State Court Tentatively Ruled Defendants, Including Co.'s Endo Health Solutions, Endo Pharma Units, Not Liable Benzinga

09:11AM EDT Endo International plc (ENDP) said that one of the first public nuisance cases filed against manufacturers of prescription opioid medications has ended with a California state court tentatively ruling that the defendants, including Endo's wholly-owned subsidiaries Endo Health Solutions Inc. and Endo Pharmaceuticals Inc., are not liable. RTTNews

07:02AM EDT California State Court Rules In Favor Of Endo In Opioid Lawsuit RTTNews

07:01AM EDT California State Court Issues Tentative Ruling in Endo's Favor Following Opioid PR Newswire

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 25, 2021

07:07AM EDT Endo International Launches XIAFLEX Television Commercial, Bent Carrot To Raise Awareness Of Peyronie's Disease RTTNews

07:01AM EDT Television Commercial, Bent Carrot, and Branded Campaign to Raise Awareness of Peyronie's Disease PR Newswire

Oct 22, 2021

07:04AM EDT Endo Int'l. Highlights Post-Hoc Data From 2 Phase 3 Studies Of XIAFLEX For Men With Peyronie's Disease Will Be Presented At Sexual Medicine Society Of North America Meeting Oct. 22 Benzinga

07:01AM EDT Analysis at Sexual Medicine Society of North America (SMSNA) Annual Meeting PR Newswire

Oct 5, 2021

05:00PM EDT Endo to Announce Third Quarter 2021 Financial Results PR Newswire

Sep 30, 2021

11:10AM EDT Endo Presents New Investigational Collagenase Clostridium Histolyticum (Cch) Survey Data At American Society For Surgery Of The Hand (Assh) Annual Meeting Benzinga

11:09AM EDT Survey Data at American Society for Surgery of the Hand (ASSH) Annual Meeting PR Newswire

Sep 28, 2021

10:52PM EDT Endo International plc (ENDP) said it has reached an agreement in principle with the Louisiana Attorney General's office to settle all opioid-related cases and claims of the state and other Louisiana governmental persons and entities for $7.5 million. RTTNews

02:00PM EDT Endo Reaches Agreement in Principle To Settle Louisiana Governmental Opioid Cases And Claims; Will Pay Total Of $7.5M Benzinga

02:00PM EDT Endo Reaches Agreement in Principle to Settle Louisiana Governmental Opioid PR Newswire

Sep 22, 2021

03:32PM EDT Why Endo International's Stock Is Trading Higher Today Benzinga

10:09AM EDT Endo Launches Generic Version Of Chantix Tablets In U.S. RTTNews

10:06AM EDT Endo Highlights Launch Of Generic Version Of Chantix Tablets In US Benzinga

10:06AM EDT Endo Launches First and Only Generic Version of Chantix(r) (varenicline) PR Newswire

Sep 10, 2021

07:36PM EDT Why Shares Of Endo International Surged On Friday Benzinga

07:36PM EDT Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher Benzinga

07:36PM EDT Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge Benzinga

07:35PM EDT Mid-Morning Market Update: Markets Mixed; Kroger Tops Q2 Views Benzinga

08:55AM EDT Benzinga Pro's Top 5 Stocks To Watch For Friday, Sept. 10, 2021: FCEL, AFRM, TTOO, APLS, ENDP Benzinga

08:00AM EDT The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test Benzinga

Sep 9, 2021

09:54PM EDT Endo International plc (ENDP) said that it has agreed to pay $50 million to settle lawsuits by New York state, Suffolk and Nassau counties, related to marketing and sale of prescription opioid medications. RTTNews

07:35PM EDT Endo Settles New York State Opioid Cases and Provides Update on Remaining PR Newswire

Aug 31, 2021

02:10PM EDT Endo Comments on Non-Infringement Ruling in VASOSTRICT(r) Patent Litigation PR Newswire

Aug 20, 2021

12:18PM EDT What's Up With Endo International's Stock Getting Hammered? Benzinga

10:15AM EDT Mid-Morning Market Update: Markets Rise; Deere Beats Q3 Expectations Benzinga

Aug 9, 2021

10:23AM EDT A Look Into Healthcare Sector Value Stocks Benzinga

09:09AM EDT RBC Capital Maintains Sector Perform on Endo International, Lowers Price Target to $5 Benzinga

Aug 6, 2021

10:01AM EDT Endo Int'l. Filing Shows Registration For Mixed Shelf Offering, No Size Disclosed Benzinga

Aug 5, 2021

05:58PM EDT Endo Raises FY21 Sales Guidance From $2.65B-$2.79B To $2.73B-$2.79B vs $2.72B Est.; Raises Adj. EPS Guidance From $1.95-$2.30 To $2.15-$2.30 vs $2.20 Est. Benzinga

05:56PM EDT Endo International Q2 Adj. EPS $0.65 Beats $0.48 Estimate, Sales $713.83M Beat $661.86M Estimate Benzinga

04:18PM EDT Endo Q2 Loss/share $0.07 Vs. Profit $0.05 Year Ago RTTNews

04:16PM EDT Endo Reports Second-Quarter 2021 Financial Results And Updates 2021 Financial PR Newswire

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 4, 2021

07:35AM EDT Endo Announces Execution Of Definitive Settlement Agreement And Release Resolving Tennessee State Court Case; Agreement Resolves All Opioid-Related Claims By Plaintiffs In Exchange For $35M Payment Benzinga

07:31AM EDT Endo Announces Execution of Definitive Settlement Agreement and Release PR Newswire

Aug 2, 2021

09:49AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Jul 29, 2021

09:14AM EDT Endo To Present Investigational Collagenase Clostridium Histolyticum Data At American Podiatric Medical Association Annual Scientific Meeting Jul. 29-Aug. 1 Benzinga

09:06AM EDT Endo Presents New Investigational Collagenase Clostridium Histolyticum Data RTTNews

Jul 22, 2021

12:35PM EDT UPDATE: Endo Int'l. Reports Settlement Would Fully, Finally Resolve Case In Exchange For $35M Payment To Be Apportioned Among All 28 Plaintiffs In Discretion Benzinga

12:34PM EDT Endo Announces Agreement in Principle to Settle Tennessee State Court Case PR Newswire

12:34PM EDT Endo Int'l. Reports Deal In Principle To Settle Tennessee Start Court Case Benzinga

Jul 20, 2021

10:10AM EDT AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK) agreed to pay up to $1.179 billion in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to settle opioid-related claims. RTTNews

Jul 19, 2021

10:25AM EDT 5 Value Stocks In The Healthcare Sector Benzinga

Jul 15, 2021

10:14PM EDT Endo International plc (ENDP) said Thursday that on July 13, 2021, the Tennessee Supreme Court denied Endo's requests for discretionary review of trial court's default judgment order and the trial court's separate order permitting the substitution of new plaintiffs in the case. RTTNews

06:57PM EDT Endo Comments on Tennessee Appeals Court Orders PR Newswire

Jul 12, 2021

09:44AM EDT Endo International Shares Down 1.8%; Hearing CitiBank Out With Call To Buy Endo International; Highlights Trial With Eagle To End This Week Benzinga

Jun 29, 2021

03:25PM EDT New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid Benzinga

Jun 28, 2021

11:07AM EDT JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst Benzinga

Jun 24, 2021

05:00PM EDT Endo to Announce Second Quarter 2021 Financial Results PR Newswire

07:31AM EDT Endo's Qwo Data to Be Presented at Cosmetic Bootcamp 2021 Benzinga

07:30AM EDT Endo's Qwo(r) (collagenase clostridium histolyticum-aaes) Data to Be Presented PR Newswire

Jun 17, 2021

11:40AM EDT Endo International Given FDA Approval For Micafungin New Formulation Benzinga

Jun 14, 2021

11:12AM EDT Endo International Option Alert: Oct 15 $7 Calls Sweep (33) near the Ask: 1938 @ $1.051 vs 5720 OI; Earnings 8/4 After Close [est] Ref=$5.87 Benzinga

Jun 11, 2021

06:52PM EDT Tennessee Court Of Appeals Issues Orders Regarding State Court Default Judgment PR Newswire

Jun 9, 2021

07:03AM EDT Paladin Labs: Health Canada Approves Wakix For Cataplexy In Adult Patients With Narcolepsy RTTNews

Jun 7, 2021

09:42AM EDT Overview Of Value Stocks In The Healthcare Sector Benzinga

May 10, 2021

04:44PM EDT FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic Benzinga

May 6, 2021

05:50PM EDT Endo International Q1 EPS $0.73 Down From $0.95 YoY, Sales $717.92M Beat $668.65M Estimate Benzinga

04:47PM EDT Endo International plc (ENDP) released a profit for first quarter that decreased from last year. RTTNews

04:18PM EDT Endo International Reports Q1 EPS Of $0.17 Vs. $0.56 Last Year RTTNews

04:16PM EDT Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial PR Newswire

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

May 3, 2021

06:06AM EDT Maverix Private Equity Announces Addition Of Michael Wasserman As Managing Partner RTTNews

06:01AM EDT Maverix Private Equity Announces Team Additions PR Newswire

Apr 29, 2021

07:51AM EDT Endo Announces Qwo Data To Be Presented At The Aesthetic Meeting 2021 Apr. 30 Benzinga

07:31AM EDT Endo's Qwo(r) (collagenase clostridium histolyticum-aaes) Data to Be Presented PR Newswire

Apr 27, 2021

04:16PM EDT Endo Implements Board Succession Plan PR Newswire

Apr 13, 2021

05:00PM EDT Endo to Announce First Quarter 2021 Financial Results PR Newswire

04:26PM EDT Endo's Phase 3 Data Evaluating Qwo For Treatment Of Cellulite In Buttocks Of Women Shows Meaningful Improvement RTTNews

04:16PM EDT Endo Highlights Publication Of Phase 3 Qwo Data In 'Dermatologic Surgery' Benzinga

04:16PM EDT Endo Announces Publication of Phase 3 Qwo(r) (collagenase clostridium PR Newswire

Apr 12, 2021

10:29AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

08:59AM EDT Endo International plc (ENDP) said that its subsidiary, Endo Ventures Limited, has reached a definitive agreement with Correvio International Srl entity, a subsidiary of Advanz Pharma, to commercialize and distribute on an exclusive basis Xydalba or dalbavancin hydrochloride in Canada. RTTNews

07:10AM EDT ADVANZ PHARMA And Endo Announce Partnership For Paladin Labs To Commercialize Xydalba In Canada RTTNews

Apr 7, 2021

09:25AM EDT Endo Says Strongly Disagrees With The Staubus Court's Orders; To Seek Review By The Tennessee Appellate Courts RTTNews

09:19AM EDT Endo International Comments On Entry Of Default Liability Judgment In Tennessee State Court Case Benzinga

09:18AM EDT Endo Comments on Entry of Default Liability Judgment in Tennessee State Court PR Newswire

Apr 5, 2021

10:07AM EDT 5 Value Stocks In The Healthcare Sector Benzinga

Mar 11, 2021

06:36PM EST Endo International plc Announces Pricing of Private Offering Of Senior Secured PR Newswire

07:38AM EST Endo International Announces Proposed Private Offering Of Senior Secured Notes RTTNews

07:34AM EST Endo International plc Announces Proposed Private Offering Of Senior Secured PR Newswire

Mar 4, 2021

07:33AM EST Endo International Commences Refinancing Of Existing $3.3 Bln Senior Secured Term Loan Due 2024 RTTNews

07:31AM EST Endo International plc Commences Refinancing of its Existing Term Loan PR Newswire

Mar 3, 2021

08:20AM EST Morgan Stanley Maintains Underweight on Endo International, Raises Price Target to $7 Benzinga

Feb 26, 2021

08:17AM EST The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida Benzinga

Feb 25, 2021

05:04PM EST Endo International Sees Q1 Adj. EPS $0.40-$0.50 vs $0.53 Est., Sales $620M-$680M vs $673.86M Est., Sees FY21 Adj. EPS $1.80-$2.30 vs $2.32 Est., Sales $2.55B-$2.79B vs $2.76B Est. Benzinga

05:02PM EST Endo International Q4 Adj. EPS $0.75 Beats $0.48 Estimate, Sales $760.22M Beat $647.12M Estimate Benzinga

04:35PM EST Endo Q4 EPS $0.51 Vs. Loss $0.96 Year Ago RTTNews

04:31PM EST Endo Reports Fourth-Quarter And Full-Year 2020 Financial Results And Introduces PR Newswire

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 24, 2021

10:17AM EST Endo International's Earnings Outlook Benzinga

Feb 19, 2021

07:25AM EST The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko Benzinga

Feb 18, 2021

08:14AM EST The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout Benzinga

Feb 17, 2021

05:00PM EST Endo to Participate at J.P. Morgan 2021 Global High Yield & Leveraged Finance PR Newswire

04:18PM EST Endo Adds Jennifer Chao To Board RTTNews

04:16PM EST Endo Appoints Jennifer Chao To Board Of Directors RTTNews

Feb 3, 2021

07:31AM EST The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision Benzinga

Jan 26, 2021

05:00PM EST Endo to Announce Fourth-Quarter and Full-Year 2020 Financial Results PR Newswire

Jan 25, 2021

03:43PM EST Endo Int'l Shares Spike To Session High On Volume Amid Report FTC Says It Has Charged Endo, Impax Labs With Illegally Preventing Competition In US Market For Oxymorphone Extended Release Benzinga

Jan 6, 2021

07:31AM EST The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping Benzinga

Jan 5, 2021

09:03AM EST Endo International plc (ENDP) said Tuesday that its subsidiary Endo Ventures Limited has entered into definitive agreements with Radius Health, Inc. (RDUS) to register, commercialize and distribute abaloparatide on an exclusive basis in Canada. Paladin Labs Inc., an operating company of Endo, will be responsible for all commercial activities related to abaloparatide. RTTNews

08:39AM EST Endo Ventures Enters Licensing Agreement For Paladin Labs To Commercialize Abaloparatide In Canada RTTNews

08:39AM EST The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data Benzinga

08:37AM EST Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize PR Newswire

08:31AM EST What Does Endo International's Debt Look Like? Benzinga

08:23AM EST Radius Health Enters Definitive Agreements With Endo Ventures For Abaloparatide RTTNews

08:22AM EST Radius Health Announces Commercial Agreement With Paladin Labs For Abaloparatide in Canada Benzinga

08:15AM EST -- Agreement incorporates TYMLOS and abaloparatide-TD -- Consideration includes upfront payment, milestones based on clinical, regulatory and commercial progression, as well as royalties -- Key first step in expanding the global footprint for the abaloparatide asset beyond the U.S. and Japan; a key focus area for the company for 2021 GlobeNewswire Inc

08:03AM EST Endo Aesthetics Launches Unbranded Campaign Designed To Eliminate Shame And Misinformation Relating To Cellulite RTTNews

08:00AM EST Endo Aesthetics Launches "Really Cellulite" Campaign PR Newswire

Jan 4, 2021

09:07AM EST Endo Launches Authorizied Generic Version Of Amitiza Capsules In U.S. Benzinga

09:06AM EST Par Pharmaceutical Begins Shipping First Authorized Generic Versions Of Mallinckrodt's Amitiza 8 Mcg And 24 Mcg Capsules RTTNews

09:03AM EST Endo Unveils Authorized Generic Version Of Amitiza Capsules In The United States RTTNews

09:02AM EST Endo Launches Authorized Generic Version of Amitiza(r) (lubiprostone) Capsules PR Newswire

Dec 18, 2020

05:00PM EST Endo to Participate at J.P. Morgan 39th Annual Healthcare Conference PR Newswire

Dec 2, 2020

09:13AM EST BioSpecifics Technologies Announces Successful Completion Of Its Acquisition By Endo RTTNews

09:10AM EST BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals PR Newswire

08:48AM EST Endo Completes Acquisition Of BioSpecifics Technologies RTTNews

08:45AM EST Endo Completes Acquisition of BioSpecifics PR Newswire

Nov 18, 2020

05:01PM EST Endo to Participate In Upcoming Investor Conferences PR Newswire

08:52AM EST Endo International plc (ENDP) said Wednesday that the Hart-Scott-Rodino waiting period for the BioSpecifics Technologies Corp. (BSTC) tender offer has expired. RTTNews

08:03AM EST Endo Reports Expiration Of HSR Waiting Period For BioSpecifics Tender Offer RTTNews

08:03AM EST Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer; Transaction Is Expected To Close In Early December 2020 Benzinga

08:02AM EST Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics PR Newswire

Nov 12, 2020

08:01AM EST Morgan Stanley Maintains Underweight on Endo International, Raises Price Target to $4 Benzinga

Nov 6, 2020

01:27PM EST SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors Of Investigation of PR Newswire

09:46AM EST Endo International shares are trading higher after the company reported better-than-expected Q3 sales results. Benzinga

Nov 5, 2020

05:27PM EST Endo Lowers FY 2020 Revenue Guidance From $2.75B-$2.8B To $2.6B-$2.7B, EPS From $2.50-$2.55 To $2.00-$2.15 Benzinga

05:25PM EST Endo International Q3 EPS $0.52 Down From $0.60 YoY, Sales $634.86M Beat $547.80M Estimate Benzinga

04:55PM EST Endo Q3 Loss/share $0.33 Vs. Loss $9.35 Year Ago RTTNews

04:50PM EST Endo Reports Third-Quarter 2020 Financial Results And Raises Full Year 2020 PR Newswire

03:57PM EST Notable Earnings Watchlist For Thursday, Nov. 5, 2020 After Market Close: NLOK, TTWO, Z, SYNA, GPRO, DBX, NWS, PTON, MCHP, MNST, UBER, YELP, WLL, WYNN, SQ, ROKU, BKNG, BMRN, CHMA, CHUY, AIG, GRPN, FLS, FLT, IAC, EA, ENDP Benzinga

08:40AM EST Endo International plc (ENDP) said Thursday it has initiated several strategic actions, including a net reduction of about 560 full-time positions from its global workforce, to further optimize its operations and increase overall efficiency. The company plans to reduce its workforce by the first half of 2023. RTTNews

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

07:50AM EST Endo International Will Record A Pre-Tax Charge Of $67M In Q3 2020 Benzinga

07:35AM EST Endo Announces Cost Savings Actions Expected To Result In Annualized Pre-Tax Cash Savings Of Approximately $85M To $95M Benzinga

07:34AM EST Endo To Cut 560 Full-time Positions; Expects Cash Savings RTTNews

07:31AM EST Endo Announces Strategic Actions to Further Position the Company for Long-Term PR Newswire

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 2, 2020

07:31AM EST Isofol Announces Licensing Agreement With Endo Ventures Limited For Paladin Labs Inc. To Commercialize Arfolitixorin In Canada Benzinga

07:03AM EST Endo Begins Tender Offer For BioSpecifics Technologies At $88.50 Per Share RTTNews

07:01AM EST Endo International plc Commences Tender Offer for All Outstanding Shares of PR Newswire

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 22, 2020

04:35PM EDT Envarsus PA Once-Daily Immunosuppressive Therapy For Kidney And Liver Transplant Patients Is Now Reimbursed In Ontario, Quebec, Manitoba And Saskatchewan Benzinga

07:06AM EDT Endo International Licensing Partner Nevakar Announces FDA Approval For Ephedrine Sulfate Injection As Ready-to-Use Vials Benzinga

07:00AM EDT Nevakar Announces FDA Approval for Ephedrine Sulfate Injection as GlobeNewswire Inc

Oct 20, 2020

08:17AM EDT The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger Benzinga

Oct 19, 2020

01:50PM EDT ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of BioSpecifics PR Newswire

01:15PM EDT Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of BioSpecifics Technologies Corp. (NASDAQ: BSTC) breached their fiduciary duties or violated the federal securities laws in connection with the companys merger with Endo International plc (NASDAQ: ENDP). GlobeNewswire Inc

10:52AM EDT Shares of Endo International plc (ENDP) are gaining 7% on Monday morning after the company said it will acquire BioSpecifics Technologies Corp. (BSTC) for an estimated equity value of $658.0 million. RTTNews

10:05AM EDT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation GlobeNewswire Inc

07:56AM EDT BioSpecifics Technologies Corp. (BSTC) agreed to be acquired by Endo International plc (ENDP) for an estimated equity value of about $658.0 million or $88.50 per share in cash. RTTNews

07:36AM EDT CORRECTION: Endo Pharmaceuticals To Acquire BioSpecifics For $88.50/Share In Cash Benzinga

07:35AM EDT Endo Pharmaceuticals To Acquire BioSpecifics For $88.50/Share In Cash Benzinga

07:34AM EDT To Acquire Endo Pharmaceuticals BioSpecifics For $88.50/Share In Cash Benzinga

07:33AM EDT Endo Intl. Agrees To Buy BioSpecifics Technologies For $88.50/shr In Cash RTTNews

07:32AM EDT Endo To Acquire BioSpecifics For Estimated Equity Value Of $658.0 Mln RTTNews

07:31AM EDT Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX(r) and Qwo(tm) PR Newswire

07:31AM EDT BioSpecifics to be Acquired by Endo Pharmaceuticals PR Newswire

Oct 9, 2020

09:06AM EDT Piper Sandler Maintains Overweight on Endo International, Raises Price Target to $6 Benzinga

07:34AM EDT Endo Aesthetics Data To Be Featured In Presentations At American Society For Dermatologic Surgery's Annual Meeting RTTNews

07:32AM EDT Endo Aesthetics Data to be Featured in Five Presentations at the American Society for Dermatologic Surgery's Annual Meeting Benzinga

07:30AM EDT Endo Aesthetics Data to be Featured in Five Presentations at the American PR Newswire

Oct 7, 2020

05:00PM EDT Endo to Announce Third Quarter 2020 Financial Results PR Newswire

Oct 6, 2020

02:35PM EDT Endo Releases First Environmental, Social and Governance Report PR Newswire

Oct 1, 2020

05:39PM EDT Endo Begins Shipment Of generic Kuvan Tablets, Powder For Oral Solution Benzinga

05:39PM EDT Endo Begins Shipment of Generic Kuvan(r) Tablets and Powder for Oral Solution PR Newswire

Sep 25, 2020

09:25AM EDT Return On Capital Employed Overview: Endo International Benzinga

07:36AM EDT A Look Into Endo International's Debt Benzinga

07:22AM EDT Endo International plc (ENDP), on Friday, said its subsidiary, Par Sterile Products LLC has entered into a non-exclusive agreement with Novavax Inc. to provide fill-finish manufacturing services at its plant in Rochester, Michigan for NVX-CoV2373, Novavax' COVID-19 vaccine candidate. Financial and other terms of the agreement remain undisclosed. RTTNews

07:02AM EDT Endo Announces Manufacturing And Services Agreement For Novavax COVID-19 Vaccine Candidate RTTNews

07:01AM EDT Endo Announces Fill-Finish Manufacturing And Services Agreement For Novavax COVID-19 Vaccine Candidate Benzinga

07:01AM EDT Endo Announces Fill-Finish Manufacturing and Services Agreement for Novavax PR Newswire

Sep 24, 2020

07:09AM EDT Endo To Present Qwo Data At Vegas Cosmetic Surgery & Aesthetic Dermatology RTTNews

07:01AM EDT Endo to Present Qwo(tm) (collagenase clostridium histolyticum-aaes) Data at PR Newswire

Sep 8, 2020

05:30PM EDT Endo to Participate at Citi 15th Annual BioPharma Virtual Conference PR Newswire

04:02PM EDT Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as GlobeNewswire Inc

Aug 21, 2020

08:30PM EDT Endo International plc Announces The Expiration And Final Tender Results Of Its PR Newswire

Aug 17, 2020

08:02AM EDT Endo International Commences Tender Offer For Outstanding 5.75% Senior Notes Due 2022 RTTNews

08:02AM EDT Endo International plc Commences Tender Offer For Any And All Of Its PR Newswire

Aug 15, 2020

06:10PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

Aug 13, 2020

01:00PM EDT ENDP DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds GlobeNewswire Inc

Aug 12, 2020

04:04PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

11:30AM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Aug 11, 2020

11:00AM EDT ENDP DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Endo International plc and Lead Plaintiff Deadline: August 18, 2020 Business Wire

08:00AM EDT The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases. GlobeNewswire Inc

Aug 10, 2020

12:04PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Reminds GlobeNewswire Inc

12:00PM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Aug 5, 2020

04:36PM EDT Endo Q2 EPS From Cont Ops $0.08 Vs Loss $0.43 Last Year RTTNews

Share